Hims & Hers Health, Inc. CEO Andrew Dudum Sold 175,661 Shares.

Filings Track
20 May
CEO of Hims & Hers Health, Inc. (Ticker: HIMS), Andrew Dudum, sold a total of 175,661 Class A common shares on May 16, 2025, across several transactions under his 10b5-1 trading plan, with prices ranging from $57.43 to $59.525. Additionally, Dudum exercised stock options acquiring 125,335 Class A common shares. Such sales by a CEO may exert pressure on the stock price, and investors should remain vigilant of market trends.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10